U.S. Capital Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Sell |
52,027
-3,984
| -7% | -$1.3M | 0.5% | 43 |
|
|
2025
Q1 | $15.1M | Sell |
56,011
-4,490
| -7% | -$1.21M | 0.46% | 49 |
|
|
2024
Q4 | $14.2M | Sell |
60,501
-999
| -2% | -$235K | 0.44% | 50 |
|
|
2024
Q3 | $16.9M | Hold |
61,500
| – | – | 0.6% | 30 |
|
|
2024
Q2 | $14.9M | Hold |
61,500
| – | – | 0.57% | 36 |
|
|
2024
Q1 | $9.19M | Hold |
61,500
| – | – | 0.35% | 62 |
|
|
2023
Q4 | $11.8M | Hold |
61,500
| – | – | 0.47% | 45 |
|
|
2023
Q3 | $10.9M | Buy |
+61,500
| New | +$10.9M | 0.49% | 41 |
|